Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Delivery
  4. Volume 22, Issue 2
  5. Article
Volume 22, Issue 2
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Background

Transdermal drug delivery systems (TDDS) offer several advantages over traditional methods such as injections and oral administration. These advantages include preventing first-pass metabolism, providing consistent and sustained activity, reducing side effects, enabling the use of short half-life drugs, improving physiological response, and enhancing patient convenience. However, the permeability of skin poses a challenge for TDDS, as it is impermeable to large molecules and hydrophilic drugs but permeable to small molecules and lipophilic drug. To overcome this barrier, researchers have investigated vesicular systems, such as transfersomes, liposomes, niosomes, and ethosomes. Among these vesicular systems, transfersomes are particularly promising for non-invasive drug administration due to their deformability and flexible membrane. They have been extensively studied for delivering anticancer drugs, insulin, corticosteroids, herbal medicines, and NSAIDs through the skin. Transfersomes have demonstrated efficacy in treating skin cancer, improving insulin delivery, enhancing site-specific corticosteroid delivery, and increasing the permeation and therapeutic effects of herbal medicines. They have also been effective in delivering pain relief with minimal side effects using NSAIDs and opioids. Transfersomes have been used for transdermal immunization and targeted drug delivery, offering site-specific release and minimizing adverse effects. Overall, transfersomes are a promising approach for transdermal drug delivery in various therapeutic applications.

Objective

The aim of the present review is to discuss the various advantages and limitations of transfersomes and their mechanism to penetration across the skin, as well as their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.

Methods

Data we searched from PubMed, Google Scholar, and ScienceDirect.

Results

In this review, we have explored the various methods of preparation of transfersomes and their application for the delivery of various drugs like anticancer, antidiabetic, NSAIDs, herbal drugs, and transdermal immunization.

Conclusion

In comparison to other vesicular systems, transfersomes are more flexible, have greater skin penetration capability, can transport systemic medicines, and are more stable. Transfersomes are capable of delivering both hydrophilic and hydrophobic drugs, making them suitable for transdermal drug delivery. The developed transfersomal gel could be used to improve medicine delivery through the skin.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018272012231213100535
2024-01-04
2025-01-16

  • From This Site

    /content/journals/cdd/10.2174/0115672018272012231213100535
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. JeongW.Y. KwonM. ChoiH.E. KimK.S. Recent advances in transdermal drug delivery systems: A review.Biomater. Res.20212512410.1186/s40824‑021‑00226‑6 34321111
     [Google Scholar]
  2. BhowmikD. KumarK.S. BhanotR. Recent advances in transdermal drug delivery system.LAP Lambert Academic Publishing2017
     [Google Scholar]
  3. ChaurasiyaP. GanjuE. UpmanyuN. RayS.K. JainP. Transfersomes: A novel technique for transdermal drug delivery.J. Drug Deliv. Ther.20199127928510.22270/jddt.v9i1.2198
     [Google Scholar]
  4. TrommerH. NeubertR.H.H. Overcoming the stratum corneum: The modulation of skin penetration. A review.Skin Pharmacol. Physiol.200619210612110.1159/000091978 16685150
     [Google Scholar]
  5. TouitouE. JungingerH.E. WeinerN.D. NagaiT. MezeiM. Liposomes as carriers for topical and transdermal delivery.J. Pharm. Sci.19948391189120310.1002/jps.2600830902 7830230
     [Google Scholar]
  6. BarryB.W. Breaching the skin’s barrier to drugs.Nat. Biotechnol.200422216516710.1038/nbt0204‑165 14755286
     [Google Scholar]
  7. RajA. C, S.C.; v, A.N.; Ivon, A.; M, N.F.N.; P, N.N.P. Lipid-based vesicles: A non-invasive tool for transdermal drug delivery.J. Pharm. Innov.20221731039105210.1007/s12247‑021‑09572‑3
     [Google Scholar]
  8. XuX. KhanM.A. BurgessD.J. Predicting hydrophilic drug encapsulation inside unilamellar liposomes.Int. J. Pharm.2012423241041810.1016/j.ijpharm.2011.12.019 22207162
     [Google Scholar]
  9. SinghD. PradhanM. NagM. SinghM.R. Vesicular system: Versatile carrier for transdermal delivery of bioactives.Artif. Cells Nanomed. Biotechnol.201543428229010.3109/21691401.2014.883401 24564350
     [Google Scholar]
  10. LangerR. Transdermal drug delivery: Past progress, current status, and future prospects.Adv. Drug Deliv. Rev.200456555755810.1016/j.addr.2003.10.021 15019745
     [Google Scholar]
  11. SolankiD. KushwahL. MotiwaleM. ChouhanV. Transferosomes-a review.World J. Pharm. Pharm. Sci.2016510435449
     [Google Scholar]
  12. Fernández-GarcíaR. LalatsaA. StattsL. Bolás-FernándezF. BallesterosM.P. SerranoD.R. Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale.Int. J. Pharm.202057311881710.1016/j.ijpharm.2019.118817 31678520
     [Google Scholar]
  13. SachanR. ParasharT. SoniyaS.V. SinghG. TyagiS. PatelC. Drug carrier transfersomes: A novel tool for transdermal drug delivery system.Inter. J. Res. Deve. Pharma. Life Sci.201322309316
     [Google Scholar]
  14. SivannarayanaP. RaniA.P. SaikishoreV. Transfersomes: Ultra deformable vesicular carrier systems in transdermal drug delivery system.Res. J. Pharm. Dos. Forms Technol.201245243255
     [Google Scholar]
  15. SarmahP.J. KalitaB. SharmaA.K. Transfersomes based transdermal drug delivery: An overview.Int J Adv Pharm Res.201341225552563
     [Google Scholar]
  16. PandeyM. ChoudhuryH. GorainB. TiongS.Q. WongG.Y.S. ChanK.X. TheyX. ChieuW.S. Site-specific vesicular drug delivery system for skin cancer: A novel approach for targeting.Gels20217421810.3390/gels7040218 34842689
     [Google Scholar]
  17. AkramM.W. JamshaidH. RehmanF.U. ZaeemM. Khan Jz, Zeb A. Transfersomes: A revolutionary nanosystem for efficient transdermal drug delivery.AAPS PharmSciTech202223118
     [Google Scholar]
  18. OpathaS.A.T. TitapiwatanakunV. ChutoprapatR. Transfersomes: A promising nanoencapsulation technique for transdermal drug delivery.Pharmaceutics202012985510.3390/pharmaceutics12090855 32916782
     [Google Scholar]
  19. ThakurL. GhodasraU. PatelN. DabhiM. Novel approaches for stability improvement in natural medicines.Pharmacogn. Rev.201159485410.4103/0973‑7847.79099 22096318
     [Google Scholar]
  20. VinodK.R. KumarM.S. AnbazhaganS. SandhyaS. SaikumarP. RohitR.T. BanjiD. Critical issues related to transfersomes - novel vesicular system.Acta Sci. Pol. Technol. Aliment.20121116782 22230977
     [Google Scholar]
  21. JiangT. WangT. LiT. MaY. ShenS. HeB. MoR. Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma.ACS Nano201812109693970110.1021/acsnano.8b03800 30183253
     [Google Scholar]
  22. ModiC. BharadiaP. Transfersomes: New dominants for transdermal drug delivery.Am J Pharm Tech Res.2012237191
     [Google Scholar]
  23. WalveJ BakliwalS RaneB PawarS. Transfersomes: A surrogated carrier for transdermal drug delivery system.201121
     [Google Scholar]
  24. JainS. UmamaheswariR. BhadraD. TripathiP. JainP. JainN. Ultradeformable liposomes: A recent tool for effective transdermal drug delivery.Indian J. Pharm. Sci.2003653223231
     [Google Scholar]
  25. El ZaafaranyG.M. AwadG.A.S. HolayelS.M. MortadaN.D. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery.Int. J. Pharm.20103971-216417210.1016/j.ijpharm.2010.06.034 20599487
     [Google Scholar]
  26. JainA.K. KumarF. Transfersomes: Ultradeformable vesicles for transdermal drug delivery.Asian J Biomater Res.2017313
     [Google Scholar]
  27. KumarP.K. KumarR.S. Review on transferosomes and transferosomal gels.J. Pharm. Res. Int.20213343B11412610.9734/jpri/2021/v33i43B32532
     [Google Scholar]
  28. KurheS.A. BavaskarK. JainA. Transferosome: A vesicular transdermal delivery system for enhanced drug permeation.J. Adv. Pharm. Technol. Res.202223138143
     [Google Scholar]
  29. LiJ. WangX. ZhangT. WangC. HuangZ. LuoX. A review on phospholipids and their main applications in drug delivery systems.Asian J. Pharma. Sci.2015102819810.1016/j.ajps.2014.09.004
     [Google Scholar]
  30. SinghS.R. Transferosme: A novel approach for transdermal drug delivery system.Intern. J. Pharma. Res.201683
     [Google Scholar]
  31. CaritáA.C. Resende de AzevedoJ. ChevalierY. ArquierD. BuriM.V. RiskeK.A. Ricci LeonardiG. BolzingerM.A. Elastic cationic liposomes for vitamin C delivery: Development, characterization and skin absorption study.Int. J. Pharm.202363812289710.1016/j.ijpharm.2023.122897 37003313
     [Google Scholar]
  32. TyagiS Prabhakar VishvakarmaDMUI Recent advancement and prospective of nanocarriers like ethosome, liposome, transferosome for therapeutic applications with topical drug delivery system.Available from: https://www.eurchembull.com/uploads/paper/1dbe7b70b6a37fe5a44596d6d999516b.pdf
    [Google Scholar]
  33. Abd El-AlimS.H. KassemA.A. BashaM. SalamaA. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation.Int. J. Pharm.201956329330310.1016/j.ijpharm.2019.04.001 30951860
     [Google Scholar]
  34. GhanbarzadehS. AramiS. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes.BioMed Res. Int.201320131710.1155/2013/616810 23936825
     [Google Scholar]
  35. KumarR. SinghM. BalaR. SethN. RanaA. Transferosomes: A novel approach for transdermal drug delivery.International Research Journal of Pharmacy.2012312024
     [Google Scholar]
  36. PatelS. PatelN. PatelK. PatelN. A Vesicular Transdermal delivery system for enhance drug Permeation-Ethosomes & Transferosomes.Internationale Pharmaceutica Sciencia.2012222434
     [Google Scholar]
  37. KumarVD SaraswathiB Kanth NPJIJoPS, Research.Transferosome: latest updates.20134114125
     [Google Scholar]
  38. GuptaA AggarwalG SinglaS Arora RJSp. Transfersomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline.development, characterization, and performance evaluation.201280410611080
     [Google Scholar]
  39. KavithaK. BharathN. Mani TTJRoJop, Biological, sciences C.Physical Permeation Enhancers for Transdermal Drug Delivery.20112466
     [Google Scholar]
  40. AnushreeP MittalA ChauhanN Alam SJJoMP, Research OP.Role of surfactants as penetration enhancer in transdermal drug delivery system2014
     [Google Scholar]
  41. RaiS PandeyV Rai GJNr, experiments. Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy.The state of the art.2017811325708
     [Google Scholar]
  42. AlkilaniA.Z. NasereddinJ. HamedR. NimrawiS. HusseinG. Abo-ZourH. DonnellyR.F. Beneath the skin: A review of current trends and future prospects of transdermal drug delivery systems.Pharmaceutics2022146115210.3390/pharmaceutics14061152 35745725
     [Google Scholar]
  43. SapkotaR. DashA.K. Liposomes and transferosomes: A breakthrough in topical and transdermal delivery.Ther. Deliv.202112214515810.4155/tde‑2020‑0122 33583219
     [Google Scholar]
  44. ChenJ LuW-L GuW LuS-S ChenZ-P Cai B-CJEoodd.Skin permeation behavior of elastic liposomes: role of formulation ingredients.2013106845856
     [Google Scholar]
  45. DuangjitS. OpanasopitP. RojanarataT. NgawhirunpatT. Eds.; Publ, T., Eds.; Effect of edge activator on characteristic and in vitro skin permeation of meloxicam loaded in elastic liposomesAdvanced Materials Research201110.4028/www.scientific.net/AMR.194‑196.537
     [Google Scholar]
  46. CevcG Blume GJBeBA-B.Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force199211041226232
     [Google Scholar]
  47. RajanR JoseS MukundVB Vasudevan DTJJoapT, ResearchTransferosomes-A vesicular transdermal delivery system for enhanced drug permeation.20112313810.4103/2231‑4040.85524
     [Google Scholar]
  48. JainS JainP UmamaheshwariR Jain NJDd, pharmacy i.Transfersomes—a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation200329910131026
     [Google Scholar]
  49. Benson HAJCddTransdermal drug delivery: penetration enhancement techniques.2005212333
     [Google Scholar]
  50. BjörklundS EngblomJ ThuressonK Sparr EJJocr.A water gradient can be used to regulate drug transport across skin.20101432191200
     [Google Scholar]
  51. CevcG GebauerD StieberJ SchätzleinA Blume GJBeBA-B.Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin.199813682201215
     [Google Scholar]
  52. ChaudharyH. KohliK. KumarV. Nano-transfersomes as a novel carrier for transdermal delivery.Int. J. Pharm.2013454136738010.1016/j.ijpharm.2013.07.031 23871739
     [Google Scholar]
  53. DhakarR.C.J.C. EvaluationP. Transfersomes-a Novel Vesicular Carrier for Enhanced Transdermal Delivery of Stavudine: Development.Characterization and Performance Evaluation2021
     [Google Scholar]
  54. PrajapatiS.T. PatelC.G. PatelC.N. Transfersomes: A vesicular carrier system for transdermal drug delivery.Asian J. Bio. Pharma. Res.201121507524
     [Google Scholar]
  55. KumarA. Transferosome: A recent approach for transdermal drug delivery.J. Drug Deliv. Ther.201885-s10010410.22270/jddt.v8i5‑s.1981
     [Google Scholar]
  56. BanghamA.D. HillM.W. MillerN. Preparation and use of liposomes as models of biological membranes. Methods in membrane biology.Springer1974168
     [Google Scholar]
  57. SinghH.P. UtrejaP. TiwaryA.K. JainS. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity.AAPS J.2009111546410.1208/s12248‑008‑9078‑8 19191031
     [Google Scholar]
  58. AbdallahM.H. Transfersomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin.LIPOSOME & NANOTECHNOLOGY2013390
     [Google Scholar]
  59. SzokaF.Jr PapahadjopoulosD. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.Proc. Natl. Acad. Sci.19787594194419810.1073/pnas.75.9.4194 279908
     [Google Scholar]
  60. RaiK. GuptaY. JainA. JainS.K. Transfersomes: Self-optimizing carriers for bioactives.PDA J. Pharm. Sci. Technol.2008625362379 19055232
     [Google Scholar]
  61. KumarA. BaddeS. KambleR. PokharkarV.B. Development and characterization of liposomal drug delivery system for nimesulide.Int. J. Pharm. Pharm. Sci.2010248789
     [Google Scholar]
  62. CharcossetC. JubanA. ValourJ.P. UrbaniakS. FessiH. Preparation of liposomes at large scale using the ethanol injection method: Effect of scale-up and injection devices.Chem. Eng. Res. Des.20159450851510.1016/j.cherd.2014.09.008
     [Google Scholar]
  63. MaestrelliF. González-RodríguezM.L. RabascoA.M. MuraP. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen–cyclodextrin complexes aimed for transdermal delivery.Int. J. Pharm.20063121-2536010.1016/j.ijpharm.2005.12.047 16469460
     [Google Scholar]
  64. CevcG. BlumeG. SchätzleinA. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo1Dedicated to the late Dr. Henri Ernest Bodde.1.J. Control. Release199745321122610.1016/S0168‑3659(96)01566‑0
     [Google Scholar]
  65. KaurC.D. Nimisha; Rizvi, D.A.; Fatima, Z.; Neema, Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels.Pharmacogn. Mag.20171351Suppl. 358710.4103/pm.pm_210_17 29142419
     [Google Scholar]
  66. BnyanR. KhanI. EhtezaziT. SaleemI. GordonS. O’NeillF. RobertsM. Formulation and optimisation of novel transfersomes for sustained release of local anaesthetic.J. Pharm. Pharmacol.201971101508151910.1111/jphp.13149 31373700
     [Google Scholar]
  67. PlanasM.E. GonzalezP. RodriguezL. SanchezS. CevcG. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes.Anesth. Analg.199275461562110.1213/00000539‑199210000‑00027 1530176
     [Google Scholar]
  68. YadavA.R. MohiteS.K. Recent advances in protein and peptide drug delivery.Res. J. Pharm. Dos. Forms Technol.202012320521210.5958/0975‑4377.2020.00035.X
     [Google Scholar]
  69. LeonyzaA. SuriniS. Optimization of sodium deoxycholate-based transfersomes for percutaneous delivery of peptides and proteins.Inter. J. Applied Pharma.201911532933210.22159/ijap.2019v11i5.33615
     [Google Scholar]
  70. PaulA. CevcG. BachhawatB.K. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.Vaccine1998162-318819510.1016/S0264‑410X(97)00185‑0 9607029
     [Google Scholar]
  71. XuJ. DingY. YangY. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.Viral Immunol.200821448349010.1089/vim.2008.0044 19115938
     [Google Scholar]
  72. RattanapakT. YoungK. RadesT. HookS. Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration.J. Pharm. Pharmacol.201264111560156910.1111/j.2042‑7158.2012.01535.x 23058043
     [Google Scholar]
  73. GargV SinghH BimbrawhS Kumar SinghS GulatiM VaidyaY Ethosomes and transfersomes.Principles, perspectives and practices2017145613633
     [Google Scholar]
  74. ShamimM.A. ShahidA. SardarP.K. YeungS. ReyesJ. KimJ. ParsaC. OrlandoR. WangJ. KellyK.M. MeyskensF.L.Jr AndresenB.T. HuangY. Transfersome encapsulated with the R-carvedilol enantiomer for skin cancer chemoprevention.Nanomaterials202313592910.3390/nano13050929 36903807
     [Google Scholar]
  75. LiY. TaiZ. MaJ. MiaoF. XinR. ShenC. ShenM. ZhuQ. ChenZ. Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma.J. Nanobiotechnology202321113910.1186/s12951‑023‑01877‑4 37118807
     [Google Scholar]
  76. KhanM.A. PanditJ. SultanaY. SultanaS. AliA. AqilM. ChauhanM. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study.Drug Deliv.201522679580210.3109/10717544.2014.902146 24735246
     [Google Scholar]
  77. AlviI.A. MadanJ. KaushikD. SardanaS. PandeyR.S. AliA. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells.Anticancer Drugs201122877478210.1097/CAD.0b013e328346c7d6 21799471
     [Google Scholar]
  78. Cronin-FentonD.P. DamkierP. LashT.L. Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.Future Oncol.201410110712210.2217/fon.13.168 24328412
     [Google Scholar]
  79. SundralingamU. ChakravarthiS. RadhakrishnanA.K. MuniyandyS. PalanisamyU.D. Efficacy of emu oil transfersomes for local transdermal delivery of 4-OH tamoxifen in the treatment of breast cancer.Pharmaceutics202012980710.3390/pharmaceutics12090807 32854385
     [Google Scholar]
  80. SharmaM. MittapellyN. BanalaV.T. UrandurS. GautamS. MarwahaD. RaiN. SinghN. GuptaA. MitraK. MishraP.R. Amalgamated microneedle array bearing ribociclib-loaded transfersomes eradicates breast cancer via CD44 targeting.Biomacromolecules202223366167510.1021/acs.biomac.1c01076 34978424
     [Google Scholar]
  81. MahmoodS. TaherM. MandalU.K. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.Int. J. Nanomedicine2014943314346 25246789
     [Google Scholar]
  82. WongC.Y. MartinezJ. DassC.R. Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.J. Pharm. Pharmacol.20166891093110810.1111/jphp.12607 27364922
     [Google Scholar]
  83. EasaN. AlanyR.G. CarewM. VangalaA. A review of non-invasive insulin delivery systems for diabetes therapy in clinical trials over the past decade.Drug Discov. Today201924244045110.1016/j.drudis.2018.11.010 30465877
     [Google Scholar]
  84. Padma PrashanthiniV. ShanmugapriyanS. ParimalaK. JaikumarS. Transferosomal gel for transdermal delivery of insulin: Formulation development and ex vivo permeation study.Intelligent Pharmacy2023
     [Google Scholar]
  85. MarwahH. GargT. RathG. GoyalA.K. Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex.Drug Deliv.20162351636164410.3109/10717544.2016.1155243 27187718
     [Google Scholar]
  86. SenyigitT. OzerO. Corticosteroids for skin delivery: challenges and new formulation opportunities.Glucocorticoids201210.5772/53909
     [Google Scholar]
  87. CevcG. BlumeG. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes®.Biochim. Biophys. Acta Biomembr.20031614215616410.1016/S0005‑2736(03)00172‑X 12896808
     [Google Scholar]
  88. DhavaleR.P. NadafS.J. BhatiaM.S. Quantitative structure property relationship assisted development of Fluocinolone acetonide loaded transfersomes for targeted delivery.J. Drug Deliv. Sci. Technol.20216510275810.1016/j.jddst.2021.102758
     [Google Scholar]
  89. FesqH. LehmannJ. KontnyA. ErdmannI. TheilingK. RotherM. RingJ. CevcG. AbeckD. Improved risk-benefit ratio for topical triamcinolone acetonide in TransfersomeR in comparison with equipotent cream and ointment: A randomized controlled trial.Br. J. Dermatol.2003149361161910.1046/j.1365‑2133.2003.05475.x 14510997
     [Google Scholar]
  90. CevcG. BlumeG. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage.Biochim. Biophys. Acta Biomembr.200416631-2617310.1016/j.bbamem.2004.01.006 15157608
     [Google Scholar]
  91. SahuA.N. MohapatraD. Nanovesicular transferosomes for the topical delivery of plant bioactives.Future Medicine202124912495
     [Google Scholar]
  92. ManasaR. ShivananjappaM. Delivering Herbal Drugs Using Nanotechnology.Advances in Novel Formulations for Drug Delivery2023449472
     [Google Scholar]
  93. AbdallahM. NeseemD. ElgazayerlyO.N. AbdelbaryA.A. Topical delivery of quercetin loaded transfersomes for wound treatment: In vitro and in vivo evaluation.Inter. J. App. Pharma.202113518919710.22159/ijap.2021v13i5.41345
     [Google Scholar]
  94. ProuilletC. MazièreJ.C. MazièreC. WattelA. BrazierM. KamelS. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway.Biochem. Pharmacol.20046771307131310.1016/j.bcp.2003.11.009 15013846
     [Google Scholar]
  95. DerakhshanianH. DjalaliM. DjazayeryA. NourijelyaniK. GhadbeigiS. PishvaH. SaedisomeoliaA. BahremandA. DehpourA.R. Quercetin prevents experimental glucocorticoid-induced osteoporosis: A comparative study with alendronate.Can. J. Physiol. Pharmacol.201391538038510.1139/cjpp‑2012‑0190 23656499
     [Google Scholar]
  96. PanditA.P. OmaseS.B. MuteV.M. A chitosan film containing quercetin-loaded transfersomes for treatment of secondary osteoporosis.Drug Deliv. Transl. Res.20201051495150610.1007/s13346‑020‑00708‑5 31942700
     [Google Scholar]
  97. IsemuraM. Catechin in human health and disease.Molecules201924352810.3390/molecules24030528 30717121
     [Google Scholar]
  98. HsiehW.C. FangC.W. SuhailM. Lam VuQ. ChuangC.H. WuP.C. Improved skin permeability and whitening effect of catechin-loaded transfersomes through topical delivery.Int. J. Pharm.202160712103010.1016/j.ijpharm.2021.121030 34438007
     [Google Scholar]
  99. PayneR. Limitations of NSAIDs for pain management: Toxicity or lack of efficacy?J. Pain200013Suppl.141810.1054/jpai.2000.16611 14622838
     [Google Scholar]
  100. MachadoG.C. Abdel-ShaheedC. UnderwoodM. DayR.O. Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain.BMJ2021372104n10410.1136/bmj.n104 33514562
     [Google Scholar]
  101. KhanMI YaqoobS MadniA AkhtarMF SohailMF Saleem, A Development and in vitro/ex vivo evaluation of lecithin-based deformable transfersomes and transfersome-based gels for combined dermal delivery of meloxicam and dexamethasone.BioMed Research International20222022
     [Google Scholar]
  102. DudhipalaN. Phasha MohammedR. Adel Ali YoussefA. BanalaN. Effect of lipid and edge activator concentration on development of aceclofenac-loaded transfersomes gel for transdermal application: in vitro and ex vivo skin permeation.Drug Dev. Ind. Pharm.20204681334134410.1080/03639045.2020.1788069 32598194
     [Google Scholar]
  103. VanajaK.S.S. MurthyS.N. ShivakumarH.N. Iontophoretic mediated intraarticular delivery of deformable liposomes of diclofenac sodium.Curr. Drug Deliv.202118442143210.2174/1567201817666201014144708 33059549
     [Google Scholar]
  104. YuanM. NiuJ. XiaoQ. YaH. ZhangY. FanY. LiL. LiX. Hyaluronan-modified transfersomes based hydrogel for enhanced transdermal delivery of indomethacin.Drug Deliv.20222911232124210.1080/10717544.2022.2053761 35403516
     [Google Scholar]
  105. BrownA.K. ChristoP.J. WuC.L. Strategies for postoperative pain management.Baillieres. Best Pract. Res. Clin. Anaesthesiol.200418470371710.1016/j.bpa.2004.05.004 15460554
     [Google Scholar]
  106. PowerI. BarrattS. Analgesic agents for the postoperative period.Nonopioids. Surg. Clin. North Am.199979227529510.1016/S0039‑6109(05)70383‑2 10352655
     [Google Scholar]
  107. HartrickC.T. Tapentadol immediate release for the relief of moderate-to-severe acute pain.Expert Opin. Pharmacother.200910162687269610.1517/14656560903313734 19795998
     [Google Scholar]
  108. PatilP. NeneS. ShahS. SinghS.B. SrivastavaS. Exploration of novel drug delivery systems in topical management of osteoarthritis.Drug Deliv. Transl. Res.202313253154610.1007/s13346‑022‑01229‑z 36031671
     [Google Scholar]
  109. DengP. Athary AbdulhaleemM. F.; Masoud, R.E.; Alamoudi, W.M.; Zakaria, M.Y. “Employment of PEGylated ultra-deformable transferosomes for transdermal delivery of tapentadol with boosted bioavailability and analgesic activity in post-surgical pain”.Int. J. Pharm.202262812227410.1016/j.ijpharm.2022.122274 36228884
     [Google Scholar]
  110. GiudiceE. CampbellJ. Needle-free vaccine delivery.Adv. Drug Deliv. Rev.2006581688910.1016/j.addr.2005.12.003 16564111
     [Google Scholar]
  111. KupperT.S. FuhlbriggeR.C. Immune surveillance in the skin: Mechanisms and clinical consequences.Nat. Rev. Immunol.20044321122210.1038/nri1310 15039758
     [Google Scholar]
  112. KauravM. MinzS. SahuK. KumarM. MadanJ. PandeyR.S. Nanoparticulate mediated transcutaneous immunization: Myth or reality.Nanomedicine20161241063108110.1016/j.nano.2015.12.372 26767517
     [Google Scholar]
  113. TeunissenM KapsenbergM BosJ Langerhans cells and related skin dendritic cells.Skin immune system19972
     [Google Scholar]
  114. ChoiM.J. MaibachH.I. Topical vaccination of DNA antigens: topical delivery of DNA antigens.Skin Pharmacol. Physiol.200316527128210.1159/000072067 12907832
     [Google Scholar]
  115. MishraD. DubeyV. AsthanaA. SarafD. JainN. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.Vaccine200624224847485510.1016/j.vaccine.2006.03.011 16600441
     [Google Scholar]
  116. WangJ. HuJ. LiF. LiuG. ZhuQ. LiuJ. MaH. PengC. SiF. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA–cationic deformable liposome complex.Exp. Dermatol.200716972472910.1111/j.1600‑0625.2007.00584.x 17697144
     [Google Scholar]
  117. MahorS. RawatA. DubeyP. GuptaP. KhatriK. GoyalA. VyasS. Cationic transfersomes based topical genetic vaccine against hepatitis B.Int. J. Pharm.20073401-2131910.1016/j.ijpharm.2007.03.006 17446015
     [Google Scholar]
  118. GuptaP.N. MishraV. SinghP. RawatA. DubeyP. MahorS. VyasS.P. Tetanus toxoid-loaded transfersomes for topical immunization.J. Pharm. Pharmacol.201057329530110.1211/0022357055515 15807984
     [Google Scholar]
  119. GuptaP.N. MishraV. RawatA. DubeyP. MahorS. JainS. ChatterjiD.P. VyasS.P. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: A comparative study.Int. J. Pharm.20052931-2738210.1016/j.ijpharm.2004.12.022 15778046
     [Google Scholar]
  120. KambojS. SainiV. MagonN. BalaS. JhawatV. Vesicular drug delivery systems: A novel approach for drug targeting.Int. J. Drug Deliv.201352121130
     [Google Scholar]
  121. LiJ. WangY. LiangR. AnX. WangK. ShenG. TuY. ZhuJ. TaoJ. Recent advances in targeted nanoparticles drug delivery to melanoma.Nanomedicine201511376979410.1016/j.nano.2014.11.006 25555352
     [Google Scholar]
  122. JangdeyM.S. KaurC.D. SarafS. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma.Artif. Cells Nanomed. Biotechnol.201947190491610.1080/21691401.2019.1578784 30856018
     [Google Scholar]
  123. ManconiM. MancaM.L. CaddeoC. ValentiD. CencettiC. Diez-SalesO. NacherA. Mir-PalomoS. TerencioM.C. DemurtasD. Gomez-FernandezJ.C. ArandaF.J. FaddaA.M. MatricardiP. Nanodesign of new self-assembling core-shell gellan-transfersomes loading baicalin and in vivo evaluation of repair response in skin.Nanomedicine201814256957910.1016/j.nano.2017.12.001 29248674
     [Google Scholar]
  124. ConaghanP.G. DicksonJ. BoltenW. CevcG. RotherM. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.Rheumatology20135271303131210.1093/rheumatology/ket133 23542612
     [Google Scholar]
  125. RotherM. ConaghanP.G. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel.J. Rheumatol.201340101742174810.3899/jrheum.130192 23996292
     [Google Scholar]
  126. PiumitaliB. NeerajU. JyotivardhanJ. Transfersomes—a nanoscience in transdermal drug delivery and its clinical advancements.Int. J. Nanosci.2020194195003310.1142/S0219581X19500339
     [Google Scholar]
  127. SeidelE.J. RotherM. RegenspurgerK. RotherI. A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome ® gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise.J. Sports Sci.2016341889510.1080/02640414.2015.1035667 25893979
     [Google Scholar]
  128. RotherM. VesterJ. BoltenW.W. KneerW. ConaghanP.G. Meta-analysis of randomized clinical trials investigating the effect of tdt 064, a gel-based formulation containing ultra-deformable phospholipid vesicles, in patients with knee osteoarthritis. Rheumatology.Rheumatology2014421710.4172/2161‑1149.1000138
     [Google Scholar]
  129. SigurgeirssonB. GhannoumM. Therapeutic potential of TDT 067 (terbinafine in Transfersome®): A carrier-based dosage form of terbinafine for onychomycosis.Expert Opin. Investig. Drugs201221101549156210.1517/13543784.2012.711315 22876754
     [Google Scholar]
  130. DominicusR. WeidnerC. TateH. KroonH.A. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis.Br. J. Dermatol.201216661360136210.1111/j.1365‑2133.2011.10766.x 22136723
     [Google Scholar]
  131. GhannoumM. IshamN. HenryW. KroonH.A. YurdakulS. Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo.Antimicrob. Agents Chemother.20125652530253410.1128/AAC.05998‑11 22354309
     [Google Scholar]
  132. ReddyY.D. SravaniA. RavisankarV. PrakashP.R. ReddyY.S.R. BhaskarN.V. Transferosomes a novel vesicular carrier for transdermal drug delivery system.J. Innov. Pharm. Biol. Sci.201522193208
     [Google Scholar]
  133. EstupiñanO.R. Garcia-ManriqueP. Blanco-LopezM.C. MatosM. GutiérrezG. Vitamin D3 loaded niosomes and transfersomes produced by ethanol injection method: identification of the critical preparation step for size control.Foods2020910136710.3390/foods9101367 32993064
     [Google Scholar]
  134. BhardwajV. ShuklaV. SinghA. MalviyaR. SharmaP. Transfersomes ultra flexible vesicles for transdermal delivery.Int. J. Pharm. Sci. Res.2010131220
     [Google Scholar]
  135. KumavatSD ChaudhariYS BoroleP DuvvuriP BuberaN ShenghaniK Transfersomes: A promising approach for transdermal drug delivery system.Asian J. pharma. sci. res.201335117
     [Google Scholar]
  136. NayakS.S. JangdeR.K. Formulation and design optimization of repaglinide loaded transferosomes for management of type II diabetes mellitus.National J. Pharma. Sci.20233111512510.22271/27889262.2023.v3.i1b.76
     [Google Scholar]
  137. GhanbarzadehS. AramiS. Formulation and evaluation of piroxicam transferosomal gel: An approach for penetration enhancement.J. Drug Deliv. Sci. Technol.201323658759010.1016/S1773‑2247(13)50089‑X
     [Google Scholar]
  138. PatelB.J. PatelJ.L. Design and development of transferosome of fluconazole for topical drug delivery system.Pharma Sci. Monitor20145
     [Google Scholar]
  139. AbdallahM.H. Abu LilaA.S. ShawkyS.M. AlmansourK. AlshammariF. KhafagyE.S. MakramT.S. Experimental design and optimization of nano-transfersomal gel to enhance the hypoglycemic activity of silymarin.Polymers202214350810.3390/polym14030508 35160498
     [Google Scholar]
  140. RamkanthS. AnithaP. GayathriR. MohanS. BabuD. Formulation and design optimization of nano-transferosomes using pioglitazone and eprosartan mesylate for concomitant therapy against diabetes and hypertension.Eur. J. Pharm. Sci.202116210581110.1016/j.ejps.2021.105811 33757828
     [Google Scholar]
  141. PatelR SinghS SinghS ShethN GendleR Development and characterization of curcumin loaded transfersome for transdermal delivery.J. pharma. sci. res.20091>471
     [Google Scholar]
  142. SundralingamU. MuniyandyS. RadhakrishnanA.K. PalanisamyU.D. Ratite oils for local transdermal therapy of 4-OH tamoxifen: development, characterization, and ex vivo evaluation.J. Liposome Res.202131321722910.1080/08982104.2020.1777155 32648792
     [Google Scholar]
  143. MauryaS.D. AggarwalS. TilakV.K. DhakarR.C. SinghA. MauryaG. Enhanced transdermal delivery of indinavir sulfate via transfersomes.Pharm. Glob. (IJCP)2010106
     [Google Scholar]
  144. AhadA. AqilM. KohliK. SultanaY. MujeebM. AliA. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan.Nanomedicine20128223724910.1016/j.nano.2011.06.004 21704600
     [Google Scholar]
  145. BalataG.F. FaisalM.M. ElghamryH.A. SabryS.A. Preparation and characterization of ivabradine HCl transfersomes for enhanced transdermal delivery.J. Drug Deliv. Sci. Technol.20206010192110.1016/j.jddst.2020.101921
     [Google Scholar]
  146. ZhengW. FangX. WangL. ZhangY. Preparation and quality assessment of itraconazole transfersomes.Int. J. Pharm.20124361-229129810.1016/j.ijpharm.2012.07.003 22796030
     [Google Scholar]
  147. QushawyM. NasrA. Abd-AlhaseebM. SwidanS. Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections.Pharmaceutics20181012610.3390/pharmaceutics10010026 29473897
     [Google Scholar]
/content/journals/cdd/10.2174/0115672018272012231213100535
Loading
Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications
Curr. Drug Deliv. 22, 160 (2025); https://doi.org/10.2174/0115672018272012231213100535
/content/journals/cdd/10.2174/0115672018272012231213100535
/content/journals/cdd/10.2174/0115672018272012231213100535
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): drug delivery; edge activator; herbal drugs; insulin; ligand conjugated transfersomes; transdermal immunization; Transfersomes

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test